Ruby Salmo, MBA, Mph
About Ruby Salmo, MBA, Mph
Ruby Salmo, MBA, MPH, serves as the Head of Data Management at Prothena Corporation, bringing extensive experience in clinical data management from various roles in the pharmaceutical industry.
Current Role at Prothena Corporation
Ruby Salmo serves as the Head of Data Management at Prothena Corporation since 2023. In this role, she oversees the management of clinical data, ensuring its integrity and compliance with regulatory standards. Her position is remote and based in New Jersey, United States.
Previous Experience in Clinical Data Management
Ruby has extensive experience in clinical data management across various organizations. She worked at UroGen Pharma as Senior Director, Head of Data Management from 2021 to 2023. Prior to that, she held the position of Director, Head of Data Management at UroGen Pharma from 2019 to 2021. Her earlier roles include Associate Director at Pacira BioSciences, Inc. and Senior Manager at both Ophthotech and Axovant Sciences.
Educational Background
Ruby Salmo holds a Master's Degree in Public Health (M.P.H.) from the Keck School of Medicine of the University of Southern California. She also earned a Master of Business Administration (MBA) from Saint Peter's University, where she studied management. Additionally, she completed her Bachelor's Degree at UC Irvine.
Career Timeline and Key Positions
Ruby's career in clinical data management spans over two decades. She began as a Clinical Data Coordinator at ICON Clinical Research from 2002 to 2005. Her career progressed through various roles, including Clinical Data Manager at Catalyst Pharmaceutical Research and Project Lead at Forest Laboratories. She has also worked at companies such as Schering-Plough, Allergan, and Baxter BioScience.
Professional Skills and Expertise
Ruby Salmo possesses a strong background in clinical data management, with expertise in data quality assurance, regulatory compliance, and team leadership. Her roles have involved managing clinical data teams and ensuring the accuracy and reliability of data for clinical trials. Her educational qualifications complement her professional skills in the healthcare and pharmaceutical sectors.